Analyst Ann Hynes of Mizuho Securities reiterated a Buy rating on Concentra Group Holdings Parent, Inc. (CON – Research Report), with a price target of $28.00.
Ann Hynes has given her Buy rating due to a combination of factors including Concentra Group Holdings Parent, Inc.’s strong financial performance and strategic acquisitions. The company reported robust Q4:24 results with a significant increase in adjusted EBITDA and revenue, despite a slight decline in patient visits per day. The acquisition of NOVA medical centers is expected to contribute positively to future earnings, providing potential upside.
Additionally, the company’s updated 2025-2027 adjusted EBITDA estimates reflect a positive growth trajectory, reinforcing investor confidence. The $28 price target is supported by a blended valuation approach, indicating a favorable outlook for Concentra’s stock. Ann Hynes believes that improvements in employer services volumes and the successful integration of NOVA will be key drivers for the company’s performance moving forward.
In another report released on March 11, Wells Fargo also maintained a Buy rating on the stock with a $25.00 price target.